ID
16915
Description
Zoledronic Acid in the Management of Patients With Asymptomatic/Early Stage Multiple Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT00216151
Link
https://clinicaltrials.gov/show/NCT00216151
Keywords
Versions (1)
- 8/14/16 8/14/16 -
Uploaded on
August 14, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Multiple Myeloma NCT00216151
Eligibility Multiple Myeloma NCT00216151
- StudyEvent: Eligibility
Similar models
Eligibility Multiple Myeloma NCT00216151
- StudyEvent: Eligibility
C0684271 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,2])
C0455471 (UMLS CUI [2])
C0039400 (UMLS CUI [1,2])
C0235996 (UMLS CUI [2])
C1287351 (UMLS CUI [3,1])
C0205216 (UMLS CUI [3,2])